VYGR
NASDAQ
US
Voyager Therapeutics, Inc. - Common Stock
$3.96
▼ $-0.03
(-0.75%)
Vol 462K
4
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$218.5M
ROE
-48.6%
Margin
-402.4%
D/E
0.00
Beta
1.29
52W
$3–$6
Wall Street Consensus
18 analysts · Apr 20268
Strong Buy
9
Buy
1
Hold
0
Sell
0
Strong Sell
94.4%
Buy Rating
Price Chart
Similar Stocks
TENX
Tenax Therapeutics Inc
$76.1M
IKT
Inhibikase Therapeutics Inc
$248.6M
KROS
Keros Therapeutics Inc
P/E 9.6
$620.3M
RNA
Atrium Therapeutics Inc
$10.9B
ELDN
Eledon Pharmaceuticals Inc
$113.4M
CAMP
CAMP4 Therapeutics Corp
$318.0M
NERV
Minerva Neurosciences Inc
$28.1M
ARCT
Arcturus Therapeutics Holdings Inc
$174.2M
Earnings
Beat rate: 50.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $-0.52 | $-0.46 | +$0.06 |
| Sep 2025 | $-0.53 | $-0.47 | +$0.06 |
| Jun 2025 | $-0.54 | $-0.57 | $-0.03 |
| Mar 2025 | $-0.46 | $-0.53 | $-0.07 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -37.3% | -37.6% | -37.6% | -37.6% | -48.9% | -48.6% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -634.6% | -253.5% | -253.5% | -253.5% | -404.9% | -402.4% |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 5.43 | 5.43 | 5.43 | 5.43 | 6.19 | 6.29 |
Key Ratios
ROA (TTM)
-37.2%
P/S (TTM)
6.98
P/B
1.0
EPS (TTM)
$-2.15
CF/Share
$1.34
Rev Growth 3Y
+28.9%
52W High
$6.27
52W Low
$2.65
$2.65
52-Week Range
$6.27
How does VYGR compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
VYGR valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
7.0
▼
46%
below
peers
(12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
1.0
▼
58%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
VYGR profitability vs Biotechnology peers
ROE
-48.6%
▲
28%
above
peers
(-67.3%)
vs Peers
vs Industry
Below avg
Net margin
-402.4%
▼
40%
below
peers
(-286.8%)
vs Peers
vs Industry
Weak
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-37.2%
▲
20%
above
peers
(-46.7%)
vs Peers
vs Industry
Below avg
VYGR financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
6.3
▲
42%
above
peers
(4.4)
vs Peers
vs Industry
Below avg
Beta
1.3
▲
33%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
VYGR fundamentals radar
VYGR
Peer median
Industry
VYGR profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
VYGR vs peers: key metrics
Latest News
No related news yet